BICLUSTER_ID : UPREG-94
PATHOGENS /2/ : streptococcus pneumoniae,ehrlichia chaffeensis
TARGETS /12/ : ANXA3, ADA, STAT1, LCN2, ABCC1, CCL8, TAP1, PDGFRA, ITGA2B, AMPD3, SERPINE1, ICAM1
Gene SetLeading Edge Genes
NETPATH IL 1 PATHWAY UPANXA3, BIRC3, LCN2, CXCL1, NFKBIE, CCL8, NFKBIA, PRKCD, POLR2K, AMPD3, SERPINE1, MT2A, ICAM1, CXCL2
NETPATH IL 2 PATHWAY DOWNKLHL21, LIMS1, UCP2, TBC1D8, PTPN6, LSP1, RGS10, MT2A, EVL, ADA, SORL1, BIRC3, ELF1, PBXIP1, TAP1, FYB, ITGA2B
NETPATH IL 6 PATHWAY UPSTAT1, GADD45B, CXCL1, CEBPD, ABCC1, CEBPB, MAP3K8, PDGFRA, NMI, MAFF, TNFRSF11B, IRF1, FOS, PRDM1
MORI SMALL PRE BII LYMPHOCYTE UP
NCI BCR 5PATHWAY
GRAHAM NORMAL QUIESCENT VS NORMAL DIVIDING UP
WEINMANN ADAPTATION TO HYPOXIA DN
LINDGREN BLADDER CANCER CLUSTER 2B
THEILGAARD NEUTROPHIL AT SKIN WOUND DN
VARELA ZMPSTE24 TARGETS UP
SWEET LUNG CANCER KRAS UP
CHEN LVAD SUPPORT OF FAILING HEART UP
HELLER HDAC TARGETS SILENCED BY METHYLATION DN
TENEDINI MEGAKARYOCYTE MARKERS
LINDSTEDT DENDRITIC CELL MATURATION B
RASHI RESPONSE TO IONIZING RADIATION 2
LINDSTEDT DENDRITIC CELL MATURATION A
CORUM CDC2-PCNA-CCNB1-GADD45B COMPLEX
GRAHAM CML QUIESCENT VS NORMAL QUIESCENT DN
LINDSTEDT DENDRITIC CELL MATURATION D
NETPATH T CELL RECEPTOR PATHWAY DOWN
COATES MACROPHAGE M1 VS M2 UP
AMIT EGF RESPONSE 40 HELA
NETPATH IL 7 PATHWAY UP
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 5
MORI EMU MYC LYMPHOMA BY ONSET TIME DN
JEON SMAD6 TARGETS UP
MITSIADES RESPONSE TO APLIDIN UP
CHAUHAN RESPONSE TO METHOXYESTRADIOL DN
THEILGAARD NEUTROPHIL AT SKIN WOUND UP
NCI IL6 7PATHWAY
BROWNE INTERFERON RESPONSIVE GENES
KLEIN PRIMARY EFFUSION LYMPHOMA DN
ALCALA APOPTOSIS
PASQUALUCCI LYMPHOMA BY GC STAGE DN
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION ERYTHROCYTE UP
WU HBX TARGETS 3 UP
BOYAULT LIVER CANCER SUBCLASS G56 DN
FRIDMAN IMMORTALIZATION DN
HINATA NFKB TARGETS KERATINOCYTE UP
MARKEY RB1 ACUTE LOF UP
KEGG NOD LIKE RECEPTOR SIGNALING PATHWAY
OSADA ASCL1 TARGETS DN
NUYTTEN EZH2 TARGETS UP
DUTTA APOPTOSIS VIA NFKB
HUANG FOXA2 TARGETS UP
DELYS THYROID CANCER UP
TSAI RESPONSE TO IONIZING RADIATION
CHUNG BLISTER CYTOTOXICITY DN
KRISHNAN FURIN TARGETS UP
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 16D DN
DIRMEIER LMP1 RESPONSE EARLY
AMIT SERUM RESPONSE 240 MCF10A
ZHAN V1 LATE DIFFERENTIATION GENES UP
ZHOU INFLAMMATORY RESPONSE LIVE UP
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 UP
RUTELLA RESPONSE TO HGF VS CSF2RB AND IL4 DN
ONDER CDH1 TARGETS 3 DN
TARTE PLASMA CELL VS B LYMPHOCYTE DN
AMIT EGF RESPONSE 120 HELA
DANG REGULATED BY MYC DN
NIELSEN MALIGNAT FIBROUS HISTIOCYTOMA UP
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS UP
PODAR RESPONSE TO ADAPHOSTIN UP
HOSHIDA LIVER CANCER SUBCLASS S1
KYNG DNA DAMAGE UP
FOSTER INFLAMMATORY RESPONSE LPS DN
LEE LIVER CANCER E2F1 UP
TAVOR CEBPA TARGETS UP
HELLER SILENCED BY METHYLATION UP
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA UP
SATO SILENCED BY DEACETYLATION IN PANCREATIC CANCER
NCI P38ALPHABETAPATHWAY
FLOTHO PEDIATRIC ALL THERAPY RESPONSE UP
GESERICK TERT TARGETS DN
KEGG T CELL RECEPTOR SIGNALING PATHWAY
AMIT SERUM RESPONSE 120 MCF10A
VANTVEER BREAST CANCER ESR1 DN
SESTO RESPONSE TO UV C3
VERHAAK AML WITH NPM1 MUTATED UP
BROCKE APOPTOSIS REVERSED BY IL6
CHANDRAN METASTASIS TOP50 DN
GEISS RESPONSE TO DSRNA UP
GRAHAM CML DIVIDING VS NORMAL QUIESCENT DN
GERY CEBP TARGETS
SPIRA SMOKERS LUNG CANCER UP
ZHAN MULTIPLE MYELOMA DN
TIAN TNF SIGNALING VIA NFKB
ROZANOV MMP14 TARGETS UP
LEE LIVER CANCER HEPATOBLAST
VALK AML WITH CEBPA
NAGASHIMA EGF SIGNALING UP
LEE EARLY T LYMPHOCYTE DN
RUGO STRESS RESPONSE SUBSET H
CHIANG LIVER CANCER SUBCLASS CTNNB1 DN
AMIT EGF RESPONSE 60 MCF10A
HINATA NFKB TARGETS FIBROBLAST UP
RHEIN ALL GLUCOCORTICOID THERAPY UP
CHARAFE BREAST CANCER LUMINAL VS BASAL DN
KYNG DNA DAMAGE BY GAMMA AND UV RADIATION
CHEN HOXA5 TARGETS 6HR UP
SMIRNOV CIRCULATING ENDOTHELIOCYTES IN CANCER UP
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL UP
NCI ATF2 PATHWAY
LEONARD HYPOXIA
ZHAN MULTIPLE MYELOMA HP DN
CROONQUIST STROMAL STIMULATION UP
BERENJENO TRANSFORMED BY RHOA REVERSIBLY DN
CHIARADONNA NEOPLASTIC TRANSFORMATION CDC25 UP
HALMOS CEBPA TARGETS UP
LEE LIVER CANCER DENA UP
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 9
WU CELL MIGRATION
BOYLAN MULTIPLE MYELOMA D DN
KHETCHOUMIAN TRIM24 TARGETS UP
KRIGE RESPONSE TO TOSEDOSTAT 24HR UP
HORIUCHI WTAP TARGETS UP
NCI CMYB PATHWAY
WOO LIVER CANCER RECURRENCE UP
GUTIERREZ WALDENSTROEMS MACROGLOBULINEMIA 1 DN
SASAI TARGETS OF CXCR6 AND PTCH1 UP
NETPATH B CELL RECEPTOR PATHWAY
CASORELLI APL SECONDARY VS DE NOVO UP
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN UP
ST INTERFERON GAMMA PATHWAY
RUTELLA RESPONSE TO CSF2RB AND IL4 DN
MULLIGHAN MLL SIGNATURE 2 UP
CHIARADONNA NEOPLASTIC TRANSFORMATION KRAS CDC25 DN
TAKEDA TARGETS OF NUP98 HOXA9 FUSION 3D UP
HARRIS HYPOXIA
FULCHER INFLAMMATORY RESPONSE LECTIN VS LPS DN
MORI PRE BI LYMPHOCYTE DN
DER IFN BETA RESPONSE UP
DEBIASI APOPTOSIS BY REOVIRUS INFECTION UP
CASORELLI ACUTE PROMYELOCYTIC LEUKEMIA UP
GARY CD5 TARGETS UP
GILDEA METASTASIS
AMIT EGF RESPONSE 20 HELA
KAN RESPONSE TO ARSENIC TRIOXIDE
BASSO CD40 SIGNALING UP
XU RESPONSE TO TRETINOIN AND NSC682994 UP
TIAN TNF SIGNALING NOT VIA NFKB
NAGASHIMA NRG1 SIGNALING UP
MARZEC IL2 SIGNALING UP
BIOCARTA FCER1 PATHWAY
SOUCEK MYC TARGETS
LINDGREN BLADDER CANCER CLUSTER 2A DN
ZERBINI RESPONSE TO SULINDAC UP
BILBAN B CLL LPL DN
WANG ESOPHAGUS CANCER VS NORMAL UP
KEGG B CELL RECEPTOR SIGNALING PATHWAY
FRIDMAN SENESCENCE UP
IZADPANAH STEM CELL ADIPOSE VS BONE UP
ZHAN MULTIPLE MYELOMA LB DN
TONKS TARGETS OF RUNX1 RUNX1T1 FUSION HSC UP
GOLDRATH ANTIGEN RESPONSE
FERRARI RESPONSE TO FENRETINIDE UP
DACOSTA LOW DOSE UV RESPONSE VIA ERCC3 XPCS UP
AMUNDSON POOR SURVIVAL AFTER GAMMA RADIATION 8G
BILD HRAS ONCOGENIC SIGNATURE
SANA RESPONSE TO IFNG UP
LIANG SILENCED BY METHYLATION 2
DAUER STAT3 TARGETS UP
ZHANG ANTIVIRAL RESPONSE TO RIBAVIRIN DN
DER IFN ALPHA RESPONSE UP
NETPATH KIT RECEPTOR PATHWAY
LEE LIVER CANCER ACOX1 UP
RUTELLA RESPONSE TO HGF DN
WU HBX TARGETS 1 UP
ADDYA ERYTHROID DIFFERENTIATION BY HEMIN
BERENJENO TRANSFORMED BY RHOA FOREVER DN
CHEN HOXA5 TARGETS 9HR UP
DAZARD UV RESPONSE CLUSTER G2
NETPATH IL 5 PATHWAY UP
AMIT SERUM RESPONSE 40 MCF10A
SEKI INFLAMMATORY RESPONSE LPS UP
HOEBEKE LYMPHOID STEM CELL UP
GRAHAM CML QUIESCENT VS CML DIVIDING UP
ZHANG RESPONSE TO IKK INHIBITOR AND TNF UP
PARK TRETINOIN RESPONSE AND PML RARA FUSION
ENGELMANN CANCER PROGENITORS UP
SANA TNF SIGNALING UP
THUM SYSTOLIC HEART FAILURE UP
MULLIGHAN MLL SIGNATURE 1 UP
LEE DIFFERENTIATING T LYMPHOCYTE
FONTAINE FOLLICULAR THYROID ADENOMA DN
SCHUETZ BREAST CANCER DUCTAL INVASIVE UP
SENESE HDAC1 AND HDAC2 TARGETS UP
ONDER CDH1 TARGETS 2 DN
REACTOME TOLL RECEPTOR CASCADES
INGA TP53 TARGETS
HAHTOLA MYCOSIS FUNGOIDES CD4 UP
CASTELLANO NRAS TARGETS UP
GARGALOVIC RESPONSE TO OXIDIZED PHOSPHOLIPIDS LIGHTYELLOW DN
ODONNELL TARGETS OF MYC AND TFRC UP
SENESE HDAC3 TARGETS UP
HOFFMANN LARGE TO SMALL PRE BII LYMPHOCYTE DN
NCI PI3KCIPATHWAY
CHARAFE BREAST CANCER LUMINAL VS MESENCHYMAL DN
UZONYI RESPONSE TO LEUKOTRIENE AND THROMBIN
XU HGF SIGNALING NOT VIA AKT1 6HR
JISON SICKLE CELL DISEASE UP
OSMAN BLADDER CANCER UP
XU HGF SIGNALING NOT VIA AKT1 48HR UP
HESS TARGETS OF HOXA9 AND MEIS1 DN
CROONQUIST NRAS SIGNALING UP
IIZUKA RECURRENT LIVER CANCER
HELLER HDAC TARGETS DN
NETPATH IL 2 PATHWAY UP
GRAHAM CML QUIESCENT VS NORMAL DIVIDING UP
BOHN PRIMARY IMMUNODEFICIENCY SYNDROM DN
OSWALD HEMATOPOIETIC STEM CELL IN COLLAGEN GEL DN
NETPATH IL 4 PATHWAY
ZUCCHI METASTASIS DN
BERTUCCI MEDULLARY VS DUCTAL BREAST CANCER UP
IVANOVA HEMATOPOIESIS MATURE CELL
DEURIG T CELL PROLYMPHOCYTIC LEUKEMIA DN
RUTELLA RESPONSE TO HGF UP
HOSHIDA LIVER CANCER LATE RECURRENCE UP
PRAMOONJAGO SOX4 TARGETS UP
FERRANDO T ALL WITH MLL ENL FUSION UP
PICCALUGA ANGIOIMMUNOBLASTIC LYMPHOMA DN
YAO TEMPORAL RESPONSE TO PROGESTERONE CLUSTER 1
Color legend
q-value10.20.050.010.0010.0001
Color
TABLE OF Q-VALUES
ehrlichia chaffeensis arkansastreptococcus pneumoniae g54ehrlichia chaffeensis libertyGeneSet Name
0.00744 0.02186 0.04640NETPATH_IL_1_PATHWAY_UP
0.00063 0.04087 0.00818NETPATH_IL_2_PATHWAY_DOWN
0.00003 0.01842 0.00150NETPATH_IL_6_PATHWAY_UP
0.17544 0.05390 0.17907MORI_SMALL_PRE_BII_LYMPHOCYTE_UP
0.06932 0.05244 0.12462NCI_BCR_5PATHWAY
0.00021 0.03257 0.01105GRAHAM_NORMAL_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.01089 0.00875 0.11374WEINMANN_ADAPTATION_TO_HYPOXIA_DN
0.00000 0.08248 0.00007LINDGREN_BLADDER_CANCER_CLUSTER_2B
0.02946 0.13865 0.13690THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_DN
0.05834 0.01900 0.00228VARELA_ZMPSTE24_TARGETS_UP
0.02631 0.07052 0.11487SWEET_LUNG_CANCER_KRAS_UP
0.14628 0.01145 0.02396CHEN_LVAD_SUPPORT_OF_FAILING_HEART_UP
0.04351 0.09151 0.14982HELLER_HDAC_TARGETS_SILENCED_BY_METHYLATION_DN
0.00000 0.11247 0.00032TENEDINI_MEGAKARYOCYTE_MARKERS
0.00007 0.00817 0.02223LINDSTEDT_DENDRITIC_CELL_MATURATION_B
0.00307 0.00271 0.09956RASHI_RESPONSE_TO_IONIZING_RADIATION_2
0.00000 0.16372 0.00000LINDSTEDT_DENDRITIC_CELL_MATURATION_A
0.17528 0.19106 0.14294CORUM_CDC2-PCNA-CCNB1-GADD45B_COMPLEX
0.01123 0.09379 0.01520GRAHAM_CML_QUIESCENT_VS_NORMAL_QUIESCENT_DN
0.00041 0.08206 0.00706LINDSTEDT_DENDRITIC_CELL_MATURATION_D
0.00211 0.09456 0.01205NETPATH_T_CELL_RECEPTOR_PATHWAY_DOWN
0.00000 0.05358 0.00740COATES_MACROPHAGE_M1_VS_M2_UP
0.03874 0.02615 0.15480AMIT_EGF_RESPONSE_40_HELA
0.00034 0.11486 0.00005NETPATH_IL_7_PATHWAY_UP
0.00697 0.03309 0.03802YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_5
0.00155 0.09386 0.00853MORI_EMU_MYC_LYMPHOMA_BY_ONSET_TIME_DN
0.00046 0.02288 0.03458JEON_SMAD6_TARGETS_UP
0.09988 0.00669 0.14846MITSIADES_RESPONSE_TO_APLIDIN_UP
0.00386 0.04001 0.05527CHAUHAN_RESPONSE_TO_METHOXYESTRADIOL_DN
0.01384 0.09013 0.01294THEILGAARD_NEUTROPHIL_AT_SKIN_WOUND_UP
0.00000 0.10802 0.00014NCI_IL6_7PATHWAY
0.00000 0.11107 0.00000BROWNE_INTERFERON_RESPONSIVE_GENES
0.00027 0.12095 0.00819KLEIN_PRIMARY_EFFUSION_LYMPHOMA_DN
0.01728 0.16647 0.11065ALCALA_APOPTOSIS
0.00026 0.11158 0.00053PASQUALUCCI_LYMPHOMA_BY_GC_STAGE_DN
0.00081 0.13995 0.06656TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_ERYTHROCYTE_UP
0.01450 0.15099 0.17063WU_HBX_TARGETS_3_UP
0.00017 0.12091 0.04554BOYAULT_LIVER_CANCER_SUBCLASS_G56_DN
0.01489 0.07577 0.15168FRIDMAN_IMMORTALIZATION_DN
0.00055 0.00568 0.00058HINATA_NFKB_TARGETS_KERATINOCYTE_UP
0.00000 0.10730 0.00000MARKEY_RB1_ACUTE_LOF_UP
0.00013 0.17463 0.00966KEGG_NOD_LIKE_RECEPTOR_SIGNALING_PATHWAY
0.00001 0.03295 0.00584OSADA_ASCL1_TARGETS_DN
0.00475 0.00276 0.11368NUYTTEN_EZH2_TARGETS_UP
0.00000 0.05455 0.00023DUTTA_APOPTOSIS_VIA_NFKB
0.16421 0.08226 0.10032HUANG_FOXA2_TARGETS_UP
0.00020 0.05377 0.02216DELYS_THYROID_CANCER_UP
0.00169 0.03105 0.05204TSAI_RESPONSE_TO_IONIZING_RADIATION
0.02663 0.06094 0.02934CHUNG_BLISTER_CYTOTOXICITY_DN
0.00678 0.11205 0.01482KRISHNAN_FURIN_TARGETS_UP
0.01934 0.10702 0.17324TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_16D_DN
0.00000 0.08905 0.00342DIRMEIER_LMP1_RESPONSE_EARLY
0.12099 0.01938 0.17684AMIT_SERUM_RESPONSE_240_MCF10A
0.00106 0.07579 0.00283ZHAN_V1_LATE_DIFFERENTIATION_GENES_UP
0.01092 0.11282 0.05362ZHOU_INFLAMMATORY_RESPONSE_LIVE_UP
0.00123 0.01828 0.00908RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_UP
0.00181 0.00340 0.01422RUTELLA_RESPONSE_TO_HGF_VS_CSF2RB_AND_IL4_DN
0.02809 0.03102 0.16184ONDER_CDH1_TARGETS_3_DN
0.00017 0.07358 0.00458TARTE_PLASMA_CELL_VS_B_LYMPHOCYTE_DN
0.07404 0.01466 0.00639AMIT_EGF_RESPONSE_120_HELA
0.00130 0.07999 0.18816DANG_REGULATED_BY_MYC_DN
0.01021 0.13119 0.04791NIELSEN_MALIGNAT_FIBROUS_HISTIOCYTOMA_UP
0.00549 0.00715 0.07034FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_UP
0.00428 0.00016 0.00465PODAR_RESPONSE_TO_ADAPHOSTIN_UP
0.00000 0.08375 0.00018HOSHIDA_LIVER_CANCER_SUBCLASS_S1
0.00021 0.00926 0.04573KYNG_DNA_DAMAGE_UP
0.00000 0.01680 0.00078FOSTER_INFLAMMATORY_RESPONSE_LPS_DN
0.00000 0.05639 0.00413LEE_LIVER_CANCER_E2F1_UP
0.00572 0.04868 0.04493TAVOR_CEBPA_TARGETS_UP
0.00000 0.17361 0.00000HELLER_SILENCED_BY_METHYLATION_UP
0.00002 0.09361 0.19454PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_UP
0.02810 0.02405 0.09089SATO_SILENCED_BY_DEACETYLATION_IN_PANCREATIC_CANCER
0.09598 0.07814 0.16868NCI_P38ALPHABETAPATHWAY
0.19775 0.12998 0.04004FLOTHO_PEDIATRIC_ALL_THERAPY_RESPONSE_UP
0.00047 0.00310 0.00164GESERICK_TERT_TARGETS_DN
0.00946 0.17024 0.05666KEGG_T_CELL_RECEPTOR_SIGNALING_PATHWAY
0.04018 0.00320 0.00533AMIT_SERUM_RESPONSE_120_MCF10A
0.00020 0.05316 0.07784VANTVEER_BREAST_CANCER_ESR1_DN
0.17152 0.01104 0.11456SESTO_RESPONSE_TO_UV_C3
0.00000 0.12533 0.00000VERHAAK_AML_WITH_NPM1_MUTATED_UP
0.00000 0.09635 0.00011BROCKE_APOPTOSIS_REVERSED_BY_IL6
0.14534 0.16467 0.09489CHANDRAN_METASTASIS_TOP50_DN
0.00175 0.03258 0.01274GEISS_RESPONSE_TO_DSRNA_UP
0.00015 0.03598 0.00118GRAHAM_CML_DIVIDING_VS_NORMAL_QUIESCENT_DN
0.01308 0.12493 0.05794GERY_CEBP_TARGETS
0.11439 0.02072 0.03806SPIRA_SMOKERS_LUNG_CANCER_UP
0.00006 0.10196 0.00049ZHAN_MULTIPLE_MYELOMA_DN
0.00003 0.16057 0.02222TIAN_TNF_SIGNALING_VIA_NFKB
0.01548 0.08267 0.15176ROZANOV_MMP14_TARGETS_UP
0.00021 0.06587 0.02333LEE_LIVER_CANCER_HEPATOBLAST
0.03309 0.09852 0.03422VALK_AML_WITH_CEBPA
0.00040 0.00045 0.01422NAGASHIMA_EGF_SIGNALING_UP
0.00000 0.06967 0.00816LEE_EARLY_T_LYMPHOCYTE_DN
0.00100 0.03314 0.00150RUGO_STRESS_RESPONSE_SUBSET_H
0.00033 0.06179 0.17601CHIANG_LIVER_CANCER_SUBCLASS_CTNNB1_DN
0.02646 0.00090 0.06686AMIT_EGF_RESPONSE_60_MCF10A
0.00358 0.02432 0.00960HINATA_NFKB_TARGETS_FIBROBLAST_UP
0.00610 0.05094 0.00739RHEIN_ALL_GLUCOCORTICOID_THERAPY_UP
0.00013 0.00034 0.04577CHARAFE_BREAST_CANCER_LUMINAL_VS_BASAL_DN
0.00117 0.03124 0.00130KYNG_DNA_DAMAGE_BY_GAMMA_AND_UV_RADIATION
0.01170 0.01846 0.13502CHEN_HOXA5_TARGETS_6HR_UP
0.00021 0.01189 0.00642SMIRNOV_CIRCULATING_ENDOTHELIOCYTES_IN_CANCER_UP
0.00488 0.01878 0.09755OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_UP
0.02314 0.03036 0.18902NCI_ATF2_PATHWAY
0.01232 0.00548 0.02395LEONARD_HYPOXIA
0.02448 0.04818 0.18359ZHAN_MULTIPLE_MYELOMA_HP_DN
0.00000 0.09861 0.00903CROONQUIST_STROMAL_STIMULATION_UP
0.00044 0.11462 0.06757BERENJENO_TRANSFORMED_BY_RHOA_REVERSIBLY_DN
0.00011 0.14745 0.01517CHIARADONNA_NEOPLASTIC_TRANSFORMATION_CDC25_UP
0.03101 0.02527 0.03077HALMOS_CEBPA_TARGETS_UP
0.00000 0.19264 0.00857LEE_LIVER_CANCER_DENA_UP
0.01067 0.16355 0.01729YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_9
0.01150 0.00050 0.18457WU_CELL_MIGRATION
0.00125 0.06977 0.00818BOYLAN_MULTIPLE_MYELOMA_D_DN
0.00000 0.02156 0.00030KHETCHOUMIAN_TRIM24_TARGETS_UP
0.02845 0.00388 0.14830KRIGE_RESPONSE_TO_TOSEDOSTAT_24HR_UP
0.00147 0.00695 0.01757HORIUCHI_WTAP_TARGETS_UP
0.01387 0.01518 0.17873NCI_CMYB_PATHWAY
0.00000 0.02446 0.05653WOO_LIVER_CANCER_RECURRENCE_UP
0.15904 0.04993 0.03335GUTIERREZ_WALDENSTROEMS_MACROGLOBULINEMIA_1_DN
0.15432 0.11472 0.03893SASAI_TARGETS_OF_CXCR6_AND_PTCH1_UP
0.00855 0.19416 0.10547NETPATH_B_CELL_RECEPTOR_PATHWAY
0.02151 0.00977 0.02398CASORELLI_APL_SECONDARY_VS_DE_NOVO_UP
0.03161 0.10354 0.04794ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_UP
0.01435 0.09655 0.03205ST_INTERFERON_GAMMA_PATHWAY
0.00000 0.03089 0.00000RUTELLA_RESPONSE_TO_CSF2RB_AND_IL4_DN
0.00468 0.15862 0.02002MULLIGHAN_MLL_SIGNATURE_2_UP
0.00000 0.02167 0.00580CHIARADONNA_NEOPLASTIC_TRANSFORMATION_KRAS_CDC25_DN
0.00000 0.08161 0.00004TAKEDA_TARGETS_OF_NUP98_HOXA9_FUSION_3D_UP
0.00160 0.10031 0.03906HARRIS_HYPOXIA
0.00000 0.12500 0.00000FULCHER_INFLAMMATORY_RESPONSE_LECTIN_VS_LPS_DN
0.00013 0.00687 0.00033MORI_PRE_BI_LYMPHOCYTE_DN
0.00030 0.11870 0.08872DER_IFN_BETA_RESPONSE_UP
0.00144 0.01803 0.00766DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_UP
0.01714 0.04079 0.02975CASORELLI_ACUTE_PROMYELOCYTIC_LEUKEMIA_UP
0.04997 0.02889 0.14278GARY_CD5_TARGETS_UP
0.00611 0.10751 0.08394GILDEA_METASTASIS
0.00013 0.04591 0.00673AMIT_EGF_RESPONSE_20_HELA
0.09168 0.04440 0.19460KAN_RESPONSE_TO_ARSENIC_TRIOXIDE
0.00000 0.03498 0.00000BASSO_CD40_SIGNALING_UP
0.00021 0.13879 0.00430XU_RESPONSE_TO_TRETINOIN_AND_NSC682994_UP
0.09628 0.00388 0.02313TIAN_TNF_SIGNALING_NOT_VIA_NFKB
0.00648 0.00022 0.00351NAGASHIMA_NRG1_SIGNALING_UP
0.00161 0.16651 0.04723MARZEC_IL2_SIGNALING_UP
0.15289 0.06296 0.08859BIOCARTA_FCER1_PATHWAY
0.00003 0.08229 0.00038SOUCEK_MYC_TARGETS
0.00871 0.00638 0.18888LINDGREN_BLADDER_CANCER_CLUSTER_2A_DN
0.07345 0.09092 0.13115ZERBINI_RESPONSE_TO_SULINDAC_UP
0.00034 0.05066 0.00006BILBAN_B_CLL_LPL_DN
0.00434 0.10110 0.15201WANG_ESOPHAGUS_CANCER_VS_NORMAL_UP
0.00262 0.06594 0.01548KEGG_B_CELL_RECEPTOR_SIGNALING_PATHWAY
0.00696 0.03706 0.08258FRIDMAN_SENESCENCE_UP
0.00277 0.04689 0.06495IZADPANAH_STEM_CELL_ADIPOSE_VS_BONE_UP
0.00000 0.08960 0.00081ZHAN_MULTIPLE_MYELOMA_LB_DN
0.01161 0.02403 0.09163TONKS_TARGETS_OF_RUNX1_RUNX1T1_FUSION_HSC_UP
0.00000 0.18885 0.00725GOLDRATH_ANTIGEN_RESPONSE
0.00947 0.01205 0.18558FERRARI_RESPONSE_TO_FENRETINIDE_UP
0.01229 0.04805 0.01970DACOSTA_LOW_DOSE_UV_RESPONSE_VIA_ERCC3_XPCS_UP
0.00790 0.06984 0.10658AMUNDSON_POOR_SURVIVAL_AFTER_GAMMA_RADIATION_8G
0.00696 0.00093 0.05938BILD_HRAS_ONCOGENIC_SIGNATURE
0.00000 0.15101 0.00245SANA_RESPONSE_TO_IFNG_UP
0.00001 0.01216 0.00000LIANG_SILENCED_BY_METHYLATION_2
0.01097 0.03237 0.06350DAUER_STAT3_TARGETS_UP
0.06898 0.02602 0.08743ZHANG_ANTIVIRAL_RESPONSE_TO_RIBAVIRIN_DN
0.00000 0.11860 0.09673DER_IFN_ALPHA_RESPONSE_UP
0.01712 0.10688 0.07782NETPATH_KIT_RECEPTOR_PATHWAY
0.00152 0.05921 0.05856LEE_LIVER_CANCER_ACOX1_UP
0.00000 0.00674 0.00008RUTELLA_RESPONSE_TO_HGF_DN
0.02293 0.07559 0.01391WU_HBX_TARGETS_1_UP
0.02809 0.09462 0.02827ADDYA_ERYTHROID_DIFFERENTIATION_BY_HEMIN
0.00705 0.02282 0.12473BERENJENO_TRANSFORMED_BY_RHOA_FOREVER_DN
0.01709 0.00050 0.02231CHEN_HOXA5_TARGETS_9HR_UP
0.03944 0.03619 0.05324DAZARD_UV_RESPONSE_CLUSTER_G2
0.00007 0.07746 0.05924NETPATH_IL_5_PATHWAY_UP
0.00705 0.00737 0.03677AMIT_SERUM_RESPONSE_40_MCF10A
0.00000 0.02093 0.00000SEKI_INFLAMMATORY_RESPONSE_LPS_UP
0.02324 0.00034 0.03894HOEBEKE_LYMPHOID_STEM_CELL_UP
0.00007 0.11160 0.00022GRAHAM_CML_QUIESCENT_VS_CML_DIVIDING_UP
0.00000 0.00231 0.00059ZHANG_RESPONSE_TO_IKK_INHIBITOR_AND_TNF_UP
0.00000 0.15242 0.00521PARK_TRETINOIN_RESPONSE_AND_PML_RARA_FUSION
0.03879 0.00380 0.04783ENGELMANN_CANCER_PROGENITORS_UP
0.00000 0.15203 0.00008SANA_TNF_SIGNALING_UP
0.00454 0.19736 0.13686THUM_SYSTOLIC_HEART_FAILURE_UP
0.00044 0.13871 0.00500MULLIGHAN_MLL_SIGNATURE_1_UP
0.00000 0.18334 0.00000LEE_DIFFERENTIATING_T_LYMPHOCYTE
0.11435 0.12710 0.01468FONTAINE_FOLLICULAR_THYROID_ADENOMA_DN
0.00000 0.13731 0.00142SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP
0.15854 0.15156 0.03587SENESE_HDAC1_AND_HDAC2_TARGETS_UP
0.00757 0.00297 0.03586ONDER_CDH1_TARGETS_2_DN
0.00786 0.15988 0.04273REACTOME_TOLL_RECEPTOR_CASCADES
0.02186 0.13640 0.01560INGA_TP53_TARGETS
0.00262 0.00067 0.02652HAHTOLA_MYCOSIS_FUNGOIDES_CD4_UP
0.00014 0.11522 0.00715CASTELLANO_NRAS_TARGETS_UP
0.09483 0.06582 0.14759GARGALOVIC_RESPONSE_TO_OXIDIZED_PHOSPHOLIPIDS_LIGHTYELLOW_DN
0.00039 0.19023 0.02393ODONNELL_TARGETS_OF_MYC_AND_TFRC_UP
0.09963 0.03264 0.17909SENESE_HDAC3_TARGETS_UP
0.02769 0.14422 0.00130HOFFMANN_LARGE_TO_SMALL_PRE_BII_LYMPHOCYTE_DN
0.00096 0.15722 0.02332NCI_PI3KCIPATHWAY
0.00100 0.00112 0.15226CHARAFE_BREAST_CANCER_LUMINAL_VS_MESENCHYMAL_DN
0.02814 0.00000 0.10221UZONYI_RESPONSE_TO_LEUKOTRIENE_AND_THROMBIN
0.01646 0.06148 0.09161XU_HGF_SIGNALING_NOT_VIA_AKT1_6HR
0.00000 0.04179 0.00099JISON_SICKLE_CELL_DISEASE_UP
0.04000 0.03886 0.03413OSMAN_BLADDER_CANCER_UP
0.00356 0.08775 0.07602XU_HGF_SIGNALING_NOT_VIA_AKT1_48HR_UP
0.00000 0.13868 0.00000HESS_TARGETS_OF_HOXA9_AND_MEIS1_DN
0.00000 0.17404 0.00000CROONQUIST_NRAS_SIGNALING_UP
0.00929 0.08004 0.17711IIZUKA_RECURRENT_LIVER_CANCER
0.01558 0.17928 0.08712HELLER_HDAC_TARGETS_DN
0.00029 0.16635 0.01786NETPATH_IL_2_PATHWAY_UP
0.00001 0.03864 0.00033GRAHAM_CML_QUIESCENT_VS_NORMAL_DIVIDING_UP
0.12686 0.15770 0.01657BOHN_PRIMARY_IMMUNODEFICIENCY_SYNDROM_DN
0.00511 0.01851 0.10357OSWALD_HEMATOPOIETIC_STEM_CELL_IN_COLLAGEN_GEL_DN
0.00465 0.07835 0.02219NETPATH_IL_4_PATHWAY
0.10538 0.01824 0.05374ZUCCHI_METASTASIS_DN
0.00000 0.10106 0.03067BERTUCCI_MEDULLARY_VS_DUCTAL_BREAST_CANCER_UP
0.00974 0.16945 0.10584IVANOVA_HEMATOPOIESIS_MATURE_CELL
0.00001 0.01586 0.00554DEURIG_T_CELL_PROLYMPHOCYTIC_LEUKEMIA_DN
0.01712 0.00850 0.06352RUTELLA_RESPONSE_TO_HGF_UP
0.00000 0.06801 0.00243HOSHIDA_LIVER_CANCER_LATE_RECURRENCE_UP
0.07569 0.00000 0.12936PRAMOONJAGO_SOX4_TARGETS_UP
0.18688 0.11265 0.10014FERRANDO_T_ALL_WITH_MLL_ENL_FUSION_UP
0.05114 0.00267 0.01248PICCALUGA_ANGIOIMMUNOBLASTIC_LYMPHOMA_DN
0.18992 0.07009 0.01294YAO_TEMPORAL_RESPONSE_TO_PROGESTERONE_CLUSTER_1